Strides Arcolab JV gets US FDA nod

New Delhi, Nov 3 (UNI) Strides Arcolab Ltd, one of the leading Indian pharmaceutical firm, today said its joint venture with Akron Inc has received US Food and Drug Administration (FDA) approval for Parnidronate Disodium injection.

The pharma firm's net profit stood Rs 105.34 cr for the quarter ended September 30 against the net loss of Rs 9.03 cr in the same quarter last year.

Total income rose to Rs 281.78 cr against Rs 214.23 cr in the corre sponding quarter last fiscal.

UNI SBA MP PK HT2036